BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Obesity
,
Pancreas
,
Nosology
,
Cisplatin
,
rs2300478
,
FABP1
,
T cell differentiation
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
receptor blocker
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Hearts of rats exposed variety of toxicants
Explore Curated Studies Results
Literature
Most Relevant Literature
Inhibition of 15-hydroxyprostaglandin dehydrogenase protects neurons from ferroptosis in ischemic st…
Working memory deficits and related disinhibition of the cAMP/PKA/CREB are alleviated by prefrontal …
Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia.
Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis …
Nimodipine activates TrkB neurotrophin receptors and induces neuroplastic and neuroprotective signal…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Angiotensin Receptor Blockers in Aortic Stenosis
Renoprotection by Pentoxifylline and Angiotensin Receptor Blocker in Chronic Kidney Disease (CKD)
Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in P…
Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease
Customized Choice of Oral P2Y12 Receptor Blocker
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ